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Background: Chlamydia trachomatis is an intracellular bacteria which consist of three biovariants; trachoma
(serovars A-C), urogenital (serovars D-K) and lymphogranuloma venereum (L1-L3), causing a wide spectrum of disease in
humans. Monocytes are considered to disseminate this pathogen throughout the body while dendritic cells (DCs) play
an important role in mediating immune response against bacterial infection. To determine the fate of C. trachomatis
within human peripheral blood monocytes and monocyte-derived DCs, these two sets of immune cells were infected
with serovars Ba, D and L2, representative of the three biovariants of C. trachomatis.
Results: Our study revealed that the different serovars primarily infect monocytes and DCs in a comparable
fashion, however undergo differential infection outcome, serovar L2 being the only candidate to inflict active
infection. Moreover, the C. trachomatis serovars Ba and D become persistent in monocytes while the serovars
predominantly suffer degradation within DCs. Effects of persistence gene Indoleamine 2, 3-dioxygenase (IDO) was
not clearly evident in the differential infection outcome. The heightened levels of inflammatory cytokines secreted
by the chlamydial infection in DCs compared to monocytes seemed to be instrumental for this consequence. The
immune genes induced in monocytes and DCs against chlamydial infection involves a different set of Toll-like
receptors, indicating that distinct intracellular signalling pathways are adopted for immune response.
Conclusion: Our results demonstrate that the host pathogen interaction in chlamydia infection is not only
serovar specific but manifests cell specific features, inducing separate immune response cascade in monocytes
and DCs.
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Chlamydia trachomatis is an obligate intracellular patho-
gen with unique biphasic developmental cycle alternating
between the infectious elementary body (EB) and the
metabolically active reticulate body (RB). Based on the
antigenic variation of the major outer membrane protein
(MOMP), the C. trachomatis isolates have been divided
into three different biovariants [1]. Serovars A, B, Ba and
C cause ocular infections, currently infecting 150 million
people worldwide [2,3]; serovars D, E, F, G, H, I, J and K
cause sexually transmitted disease with more than 90 mil-
lion new cases of genital infections occurring every year
[4,5] and serovars L1, L2 and L3 cause lymphgranuloma* Correspondence: baishakhid2004@gmail.com
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with recent outbreaks in Western Europe [6,7]. Compara-
tive genomic studies demonstrate that the genome of C.
trachomatis serovars are strikingly similar to each other
and share more than 99% identity [8,9]. Genetic differ-
ences were observed centring around the plasticity zone
i.e. ~50 kb region near the predicted termination origin
of the genome, experiencing a higher degree of DNA ar-
rangement [10], MOMP and members of polymorphic
membrane protein (pmp) gene family [11]. However the
occurrence of quantitatively different infections by differ-
ent serovars within a given host has been intriguing. In
vivo studies infecting mice intranasally [12] or intravagin-
ally [13] with different serovars of C. trachomatis has re-
vealed a great deal of variation in infection kinetics.
Genome analysis could reveal that a functional tryptophantd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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lence factors underlying this distinct tropism in terms of
organ specific disease termed as organotropism [14]. Stud-
ies including LGV serovars confirmed the observation that
the variability resided mainly in the plasticity zone [15].
Chlamydia primarily targets the host epithelial cells
and resides within distinct membrane bound vacuoles
termed as chlamydial inclusion. The chlamydia prolifer-
ate within inclusion and inhibits their acidification by
avoiding fusion with lysosomal compartments [16,17].
However the association of C. trachomatis with reactive
arthritis have raised questions how chlamydia is trans-
ported from the site of infection to the site of inflamma-
tory disease in the joints or vasculature [18-20]. Studies
have shown that the C. trachomatis infection is charac-
terized by infiltration with polymorphonuclear leukocyte
(PMNs) in the acute phase and mononuclear cells in the
chronic phase [21]. Hence there have been suggestions
that circulating monocytes delivers the pathogen to other
organs and initiate immunological response and inflam-
mation. The role of C. pneumoniae infected monocytes as
a vector, transmitting the pathogen to vascular wall, has
been elucidated earlier [22]. The C. trachomatis infection
of monocytes in vitro, have mostly resulted in noncultiva-
ble state in which the bacteria although metabolically ac-
tive could not produce active infectious particle when
recultured in HeLa cells [23,24].
Dendritic cells (DCs) are the first professional antigen
presenting cells encountering the bacteria after initial in-
fection. DCs are very efficient in processing and present-
ing bacterial antigens and play a crucial role in activating
T cell-dependent immune response [25,26]. Studies have
illustrated the role of DCs to evoke strong immune re-
sponses against chlamydial infections by stimulating T cell
reaction [27,28]. There are contrasting evidences of the
fate of C. trachomatis within DCs; there has been observa-
tions that C. trachomatis inclusion fuses with lysosomal
compartment [29] while another study confirmed that the
chlamydial inclusion did not colocalize with lysosome
associated membrane protein (Lamp) 1 or Major histo-
compatibility complex (MHC) II compartments [30]. C.
trachomatis infection of DCs was characterized by up-
regulation of co-stimulatory molecules and secretion of
inflammatory cytokines [31]. Previous studies have im-
plicated cytokines IFN-γ as well TNF of inducing indo-
leamine 2,3-dioxygenase (IDO), an enzyme catalysing
the degradation of tryptophan leading to chlamydial
growth arrest [32-34]. The presence of a functional
tryptophan synthase in the urogenital serovars while its
absence in the ocular serovars [35,36] has been consid-
ered to be pivotal. The genital serovars survive by util-
izing indole produced by vaginal microbial flora as a
substrate for tryptophan synthesis in IDO induced
tryptophan-depleted culture medium [37].However, little is known about the growth characteris-
tics of the different biovariants of C. trachomatis in
monocytes and DCs -the two major immune cells that
the bacterium encounters during infection. Hence we se-
lected three serovars Ba, D and L2; representative of the
ocular, urogenital and lymphogranuloma serovars re-
spectively, for comparative study in human monocytes
and monocyte- derived DCs. In our study we observed
the chlamydial morphology within infected monocytes
and DCs; analyzed their metabolic activity and could il-
lustrate the cytokine induced inflammatory response.
We were also able to propose the distinct immune re-




Chlamydia trachomatis serovars D/UW-3/Cx(ATCC-
VR885) and serotype LGV II strain 434(ATCC-VR902B)
were kindly provided by Prof Andreas Klos (Medical
Microbiology and Hospital Epidemiology, Hannover Med-
ical School, Germany) and Chlamydia trachomatis sero-
type Ba Apache-2(ATCC-VR347) was kindly sent by
Prof Eberhard Straube (Institute of Medical Microbiology,
Friedrich Schiller University of Jena, Jena, Germany).
Bacterial stocks were prepared as described previously
[38]. Briefly, HeLa cell monolayers infected with C. tracho-
matis serovar Ba, D and L2 EBs were cultivated at 37°C
and 5% CO2 in Earle's MEM containing glutamine, sup-
plemented with 10% fetal calf serum (FCS), 0.1 M nones-
sential amino acids, and 1 mM sodium pyruvate (PAA
Laboratories, Pasching, Germany) along with 1 μg/ml cy-
cloheximide (Sigma-Aldrich, Steinheim, Germany). EBs
from infected cells were harvested at 48 hours (Serovar
L2) to 72 hours (Serovar Ba and Serovar D) p.i., purified
by 2 step ultracentrifugation and collected in transport
medium (1x PBS, including 6.86% saccharose, 40 μg/ml
Gentamicin, 0.002% Phenol red, 2% FCS). The final
stock was stored in small aliquots in transport medium
at −80°C until use. Mock control was prepared following
the complete propagation, harvest and purification proced-
ure for EBs in the absence of C. trachomatis infection. All
the stocks were free of Mycoplasma as tested by Venor
GeM kit (Minerva Biolabs, Berlin, Germany). To quantify
the EB, the inclusions were counted and the EB determined
as inclusion-forming-units (IFU)/ml. For heat inactivation,
EBs of C. trachomatis serovars Ba, D and L2 were treated
at 75°C for 30 minutes. All the plastic wares were obtained
from Greiner Bio-One (Greiner Bio-One GmbH, Fricken-
hausen, Germany) unless otherwise mentioned.
Culture of monocytes and monocyte-derived DCs
Heparinized buffy coats from healthy blood donors were
obtained from Blutspendedienst NSTOB Springe, Bremen,
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collected from volunteer donors under informed consent
according to the current German hemotherapy guidelines
[39]. Peripheral blood mononuclear cells (PBMCs) were
isolated by Ficoll-Hypaque density gradient centrifugation
using Lymphocyte Separation Medium (PAA Laborator-
ies, Pasching, Germany). For each experiment a different
blood donor was used. Monocytes were isolated by nega-
tive selection using the Monocyte Isolation kit II (Miltenyi
Biotec GmbH, Bergisch Gladbach, Germany) according to
manufacturer’s protocol (monocyte purity >90%).
Monocytes were seeded on Poly L-Lysine (0.01%) coated
24-well plate at a density of 3×105, allowed to adhere
for 2 hours before infection and cultured in RPMI-1640
(PAA Laboratories, Pasching, Germany) containing 10%
FCS. For DCs, 3×105 monocytes were cultured in RPMI-
1640 medium with autologous serum in 24-well plate for
7 days in the presence of IL-4 (1000 U/mL) (R&D
Systems, Wiesbaden, Germany) and GM-CSF (500 U/mL)
(Novartis Pharma, Nurnberg, Germany) as described pre-
viously [40].
Infection of monocyte and monocyte-derived DC
Monocytes and the monocyte-derived DCs were infected
with C. trachomatis serovars Ba, D and L2 at a multipli-
city of infection (MOI) of 3 by centrifugation for 30 min
at 400 × g with further incubation for 30 min at 37°C in
5% CO2. Following incubation, the cells were washed
with phosphate-buffered saline (PBS) to remove extra-
cellular bacteria. Fresh RPMI-1640 containing 10% FCS
was added to infected monocytes and RPMI-1640 with
autologous serum was added to infected DCs. The in-
fected cultures were incubated at 37°C and 5% CO2 for
intended durations. For immunofluorescence, cells were
grown on coverslips. Infected cells were harvested by rub-
ber scraper at different time points as per experimental
protocol. The cell pellets for PCR/reinfection as well as
supernatants for cytokine analysis were stored at −80°C.
Mock infected controls were prepared for every set of ex-
periment to assess the contribution of host cell debris.
Control samples were routinely checked for the presence
of chlamydia antigens in the donor samples by immuno-
fluorescence microscopy.
Immunofluorescence microscopy
The infected monocytes and DCs after intended incuba-
tion were fixed in 2% para-formaldehyde for 10 min and
washed 3 times in PBS. Cells were permeabilized with
0.5% TritonX-100 for 3 minutes. Following fixation, the
cells were blocked with PBS containing 1% BSA and 1%
FCS. Genus-specific fluorescein isothiocyanate (FITC)-
labelled monoclonal antibody (Pathfinder Chlamydia Con-
firmation System; Bio-Rad, Redmond, WA) was used to
stain the chlamydial inclusions, while the monocytes andDCs were counterstained with Evan’s Blue at room
temperature for 45 min. The samples were then washed
once with PBS and then washed twice with PBS/DAPI
(1:2500) to stain the cell nuclei. Images were captured in
10 random fields with a fluorescence microscope (Leica
DMLB, Germany) with standard filters at 63X magnifica-
tion. ImageJ was used to count the number of inclusions/
cells in replicate samples. Data from 3 independent experi-
ments were combined to calculate the mean and standard
deviation.Analysis of the infectivity of C. trachomatis in
monocytes/DCs
Cells harvested at different time points were lysed in an
ultrasonic sonicator bath (Jürgen’s Hannover, Germany).
Cell lysates were used to infect HeLa cells seeded on cov-
erslips and cultured in MEM media containing 1 μg/ml
cycloheximide at 37°C in 5% CO2 for the intended dur-
ation. At the end of the infection period, cells were
fixed for 10 min in absolute methanol, air-dried, and stained
using FITC-labelled monoclonal antibody (Pathfinder Chla-
mydia Confirmation System; Bio-Rad, Redmond, WA) and
counterstained with Evan’s blue. Images were captured
in 10 random fields with a fluorescence microscope
(Leica DMLB, Germany) with standard filters at 40X
magnification. The inclusions were counted as de-
scribed under section Immunofluorescence microscopy.
Data from 3 independent experiments were combined
to calculate the mean and standard deviation.Gene expression analysis by real-time PCR
For the analysis of chlamydial gene expression, infected
cells were harvested at different time points and real-
time PCR was performed targeting the 16S rRNA gene
as described previously [34]. To analyse chlamydial de-
velopmental phase, expression of genes euo, ompA and
omcB were performed. All the primers were ordered from
Eurofins MWG Operon (Additional file 1: Figure S1).
Briefly, total RNA was isolated from the cell pellets of in-
fected monocytes or DCs using the Macherey Nagel kit
(Macherey-Nagel GmbH, Dueren, Germany). 500 nano-
gram of RNA was reverse-transcribed from each sample
using the Eurogentec Reverse-Transcription Kit. Real-time
PCR was performed using the qPCR Core kit (Eurogentec)
in Roche Lightcycler 480 system. The gene expression
levels were calculated by the delta-delta Ct (ddCt) method
[41], normalized to 16S in case of chlamydial genes and to
18S for host genes, and compared to the mock sample as
the reference gene. The specificity and identity of the
amplified products were determined using Light Cycler
480 melting curve analysis software. Data from 3 inde-
pendent experiments with pool of 2 donors were com-
bined to calculate the mean and standard deviation.
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The level of the cytokines IL-1β, IL-6, IL-8, IL-10, TNF
and IL-12p70 were measured in the supernatants of the
infected monocytes and DCs collected 1 day p.i. by Cy-
tometric Bead Array (Human Inflammatory Cytokines
Kit; BD Biosciences, San Diego, CA) according to the
manufacturer's instruction. In brief, 50 μL of human in-
flammation capture bead suspension and 50 μL of
phycoerythrin detection reagent were added to an equal
amount of samples or standard dilution and incubated
for 3 hours at room temperature in the dark. The mono-
cyte samples were diluted 1:2 and DCs samples were di-
luted 1:4 with assay diluent to have sample data within
the range of the standard curve. Subsequently, samples
were washed with wash buffer and centrifuged at 200 × g
at room temperature for 5 minutes. The samples were fur-
ther fixed with 2% paraformaldehyde for 30 minutes. The
supernatant was discarded and 300 μL of wash buffer was
added. Samples were then analysed on a BD FACS Calibur
flow cytometer (BD Biosciences, Heidelberg, Germany).
The data was analyzed using the FCAP array software (BD
Biosciences). Data from 3 independent experiments with
pool of 2 donors were combined to calculate the mean
and standard deviation.Innate and adaptive immune response array
The Human Innate and Adaptive Immune response Array
(PAHS-052) was performed using the SYBR green-based
RT2 Profiler system (SA Biosciences, Frederick, MD). This
PCR array is a pathway focused array that contains a set of
84 related genes involved in the inflammatory immune re-
sponse. This assay also contains 5 housekeeping genes and
3 other reaction controls to assess genomic DNA contam-
ination, RNA quality, and general PCR performance. Total
RNA from infected monocytes and DCs were extracted
using Macherey Nagel kit (Macherey-Nagel GmbH, Due-
ren, Germany). Due to the low RNA concentration, mono-
cyte RNA sample were amplified by RT2 PreAmp PCR
master mix (SA Biosciences, Frederick, MD). Equal amount
of RNA from each sample was reverse-transcribed to
cDNA by using Reverse-transcription mix preceded by a
genomic DNA elimination step; both provided in the kit.
The amplification of the immune genes in the samples was
investigated by real-time PCR on Roche Light Cycler 480
according to the manufacturer's instructions. Data analysis
was performed using manufacturer’s program and is based
on the ddCt method, with normalization of the raw data to
the panel of housekeeping genes provided in the array. The
genes showing modulation by 1.5 fold up or down were
only selected for further analysis. Functional annotations of
the selected genes were carried out by the bioinformatics
software David for Bioinformatics. Three independent ex-
periments with a pool of 2 donors each were analyzed.Statistical analysis
Statistical evaluation of the data was done using Graph-
Pad Prism 5 software. Student t-test was performed for
simple comparison between 2 means. For multiple com-
parisons, the results were analysed by two-way ANOVA
followed by Bonferoni’s post-test. p < 0.05 was consid-
ered statistically significant. All shown data are represen-
tative for at least 3 independent experiments.
Results
Chlamydia trachomatis infect monocytes and
monocyte-derived DCs in a comparable manner
Monocytes isolated from human peripheral blood mono-
nuclear cells (PBMCs) and monocyte-derived DCs were
infected with C. trachomatis serovars Ba, D and L2
(Figure 1). Results show that all the three serovars were
capable of infecting both the monocytes and DCs and
form inclusions as detected by immunofluorescence
microscopy 2 days post infection (p.i.). However, the in-
clusions were smaller in size compared to typical inclu-
sions that have been reported in HeLa cells (Additional
file 2: Figure S2). The inclusion morphology and stain-
ing intensity varied between the infected monocytes
and DCs.
In monocytes, the percentage of infected cells were
comparable among the three serovars and did not seem
to change even when the infection duration was ex-
tended to 3 days (Table 1). For DCs, the percentage of
infected cells were similar for serovars Ba and D but ser-
ovar L2 showed a higher infection rate as compared to
the other two (Table 1). However, the infection rate de-
clined remarkably for all the three serovars when in-
fected for 3 days. The infection rate was nevertheless
much lower in both monocytes and DCs than in HeLa.
Mock controls were prepared for each round of experi-
ments which showed absence of chlamydial antigens in
the donors (Additional file 3: Figure S3).
Differential development of C. trachomatis serovar L2 in
monocytes and DCs
In our study, we further investigated the survival and
re-infection potential of chlamydia serovars after the
primary infection of monocytes and DCs. Chlamydia-
infected monocytes and DCs were harvested 2 days p.i.
and passaged onto HeLa cell confluent monolayer.
HeLa cells were investigated by immunofluorescence
microscopy 2 days p.i. and the inclusions were counted.
The serovars Ba and the D were not able to produce
inclusions in HeLa cells after infecting either monocytes
or DCs for 2 days. Only scattered antigens could be de-
tected (Figure 2). Interestingly, serovar L2 produced in-
clusions in HeLa cells after infecting both monocytes
and DCs (Figure 2). There was no recovery of infectious
progeny from serovars Ba and D even with longer
Figure 1 Immunofluorescence microscopy of infected monocytes and monocyte-derived Dendritic cells (DCs). Monocytes (upper panel)
and monocyte-derived DCs (lower panel) were infected with C. trachomatis serovars Ba, D and L2 (MOI-3) for 2 days. Chlamydial inclusions (green)
were stained with FITC conjugated anti-chlamydia LPS antibody and counterstained with Evans Blue. Pictures were taken at 63X magnification
with Leica DMLB. The figures are representative of 3 independent experiments.
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in HeLa cells was carried out for a longer duration
(72 hours) (data not shown). In the case of serovar L2,
passaging for longer time did not yield a higher number
of infectious progeny.
Metabolic activity of chlamydia within infected
monocytes and DCs
To characterize the metabolic activity of chlamydiae in
monocytes and DCs, we investigated the expression of
16S rRNA gene transcripts which reflects the growth
rate and/or metabolic activity of chlamydiae in the cells
[40]. The expression of 16S rRNA in chlamydiae-
infected monocytes and DCs was assessed over 3 days
after infection.
16S rRNA was highly expressed in the infected mono-
cytes for all three chlamydia serovars Ba, D and L2Table 1 Comparison of infection rate in monocytes and
monocyte-derived DCs infected with C. trachomatis
serovars Ba, D and L2
Infection percentage (%)













Monocytes 32 ± 5 34.3 ± 6 33.6 ± 6 36.6 ± 7 44 ± 6 42 ± 3
DC 26.8 ± 2 20.7 ± 2 29.4 ± 1 24.4 ± 1 39.9 ± 4 25.4 ± 2
HeLa 78 ± 7 81.3 ± 6 83.5 ± 4 85.1 ± 7 88.7 ± 3 84.2 ± 3
Monocytes, DCs and HeLa cells were infected with Chlamydia trachomatis
serovars Ba, D and L2 and stained with anti-Chlamydia LPS antibody at 2 day
and 3 day p.i.. Quantification of chlamydia infected cells were done by counting
total number of cells (indicated by nuclei staining) and cells positive for
Chlamydia and from 15 pictures The mean and ± SD were calculated from
three independent experiments.throughout the 3 day time course of infection (Figure 3).
The heightened metabolic activity of the intracellular
chlamydia did not seem to decline with a longer dur-
ation, thus indicating that all the serovars were viable
and metabolically active within the monocytes.
In contrast 16S rRNA expression level was negligible
in DCs for serovars Ba and D at 1 day p.i. and further
declined with infection progression (Figure 3). Serovar
L2 displayed highly significant expression of 16S rRNA
at 1and 2 day p.i. Although the level declined on the
3 day p.i., the expression remained significant (Figure 3).
To further characterize developmental state of chla-
mydial serovars within the infected monocytes and DCs,
gene expression of euo, ompA and omcB were investi-
gated. Each of these genes are known to be expressed at
different developmental stages of chlamydiae (early, mid
and late phase respectively), and have previously re-
ported to be transcriptionally altered during chlamydial
growth in human monocytes and DCs [40,42]. Figure 4
depicts the expression of the three genes in monocytes
and DCs respectively. Expression of the 3 genes within
serovars Ba and D in both cell types was similar and
stable, albeit at low levels in all the three time points
that were investigated. Serovar L2 depicted a different
pattern; early stage gene euo was significantly expressed
1 day p.i. compared to serovars Ba and D, gradually
diminishing with time in both monocytes and DCs. The
expression of mid-cycle gene ompA for serovar L2, al-
though higher than the serovars Ba and D, was not statis-
tically significant in infected monocytes. The expression
for ompA within infected DCs peaked at 2 day p.i. signifi-
cant to both serovars Ba and D. Expression of late stage
gene omcB increased significantly 3 days p.i. for serovar
Figure 2 Infectivity assay of Chlamydiae infected monocytes and monocyte-derived DCs. Monocytes (upper panel) and human monocyte-derived
DCs (lower panel) were infected with C. trachomatis serovars Ba, D and L2 (MOI-3) for 2 days and were further passaged in HeLa cells for
2 days. Chlamydial inclusions (green) were stained with FITC conjugated anti-chlamydia LPS antibody and counterstained with Evans Blue.
Pictures taken at 40X magnification with Leica DMLB. The figures are representative of 3 independent experiments.
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Indolamine 2, 3-dioxygenase expression is down-regulated
in monocytes and upregulated in DCs by C. trachomatis
serovar L2
One aspect of chlamydial infection is the gamma-interferon
(IFN-γ) mediated induction of Indolamine-2, 3-dioxygenase
(IDO), an enzyme catabolizing breakdown of tryptophan in
culture media. The unavailability of this essential amino
acid can lead to chlamydial growth arrest termed as persist-
ence [43]. The role of TNF-α mediated IDO induction in
DCs [44] as well IFN-γ independent IDO activation in
monocytic THP-1 cells have been reported earlier [45].
We considered that the level of IDO gene expression
could be crucial in understanding the contrasting infec-
tion outcome by the chlamydia serovars in monocytes
and monocyte-derived DCs. Hence the expression of
IDO gene in chlamydiae-infected monocytes and DCs
was detected over 3 days post infection.
Monocytes, infected with serovars Ba and D expressed
higher levels of IDO 1 day post infection (Figure 5).
Contrastingly, IDO expression by serovar L2 infected
monocytes was significantly down-regulated 1 day p.i
compared to serovar D. On the other days of infection
the trend was similar but not significant.
IDO expression was significantly up-regulated in DCs
infected with serovar L2 (Figure 5) compared to sero-
vars Ba and D. IDO expression declined throughout the
infection course for all the servers, however maintaining a
significant expression for serovar L2 infection.Attempts were made to enhance chlamydial recovery
from infected monocytes and DCs by addition of Tryp-
tophan, known to be depleted by IDO during chlamydial
infection [34,46]. However the infected cultures supple-
mented with Tryptophan (200 μg/ml) when passaged on
HeLa cells could not abrogate the growth arrest; chla-
mydial inclusions could not be recovered from serovar
Ba and D cultures (data not shown). However, Serovar
L2 could produce chlamydial inclusions irrespective of
Tryptophan.
Differential cytokine response induced in monocytes and
DCs by chlamydial infection
We investigated the role of cytokines in mediating con-
trasting infection outcome of chlamydia infection the
monocytes and DCs. Supernatants were collected from
monocyte and monocyte-derived DCs culture infected
with C. trachomatis serovars Ba, D and L2 at 1 day p.i.
and cytokine responses were assessed by Cytokine Bead
Array.
As depicted in Figure 6, infection of monocytes and
monocyte-derived DCs with chlamydial serovars Ba, D
and L2 could induce detectable secretion of cytokines
IL-8, IL-6, IL-1β, IL-10 and TNF. Production of IL-
12p70 was below the standards (data not shown).
Pro-inflammatory cytokines IL-1β and TNF was ele-
vated in the chlamydiae infected monocytes than the
mock control, however were not statistically significant.
The level of cytokines IL-6 and IL-8 in infected mono-
cytes showed no statistical difference with mock control.
The anti-inflammatory cytokine IL-10 was induced in
Figure 3 Metabolic activity of intracellular chlamydiae in infected monocytes and monocyte-derived DCs. Monocytes and monocyte-derived
DCs were infected with C. trachomatis serovars Ba, D and L2 (MOI-3) and mock control. 16S rRNA gene copy numbers was determined by isolating
RNA at the indicated time points, followed by real-time PCR as described in materials and methods. 16S rRNA fold change was normalized to 18S rRNA
and determined by ddCt method with mock sample as reference gene. The mean of 3 independent experiments is shown and each experiment is
pool of 2 donors. ***P < 0.001, **P < 0.01, *P < 0.05.
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secreting significant amounts compared to mock. DCs
infected with serovars D and L2 showed significantly
up-regulated levels of TNF. The other pro-inflammatory
cytokine IL-1β although secreted in higher amounts
within serovar L2 infected DCs, than the other serovars or
mock, was not significant. DCs infection resulted in sig-
nificant production of inflammatory cytokines IL-8 and
IL-6. The anti-inflammatory cytokine IL-10 levels were
low in the infected DCs and were not statistically signifi-
cant to the mock control. To understand LPS contribution
in the observed cytokine responses, monocytes and DCs
were infected with heat-killed C. trachomatis serovars Ba,
D and L2 EBs at MOI-3 and the cytokine levels wereinvestigated (Additional file 4: Figure S4). Heat-killed EBs
for serovar Ba and D induced significantly low level of IL-
8 and IL-6 in monocytes while the TNF levels were low in
DCs for serovar D and L2. The most remarkable observa-
tion was the negligible induction of IL-10 by heat-killed
EBs from all 3 serovars in monocytes which was highly
significant.
Immune gene response to C. trachomatis infected
monocytes and DCs
To determine the host genes activated by chlamydia in-
fection, the immune response was analyzed by Human
innate and Adaptive Immune response array. Genes dif-
ferentially regulated 1.5 fold up or down in monocytes
Figure 4 Quantification of euo, ompA and omcB gene expression in chlamydiae infected monocytes and monocyte-derived DCs.
Monocytes and monocyte-derived DCs were infected with C. trachomatis serovars Ba, D and L2 (MOI-3) and mock control. Copy numbers of euo,
ompA and omcB genes were determined by isolating RNA at the indicated time points, followed by real-time PCR as described in materials and
methods. Gene fold change was normalized to chlamydial 16S rRNA and determined by ddCt method with mock sample as reference gene. The
mean of 3 independent experiments is shown and each experiment is pool of 2 donors. ***P < 0.001, **P < 0.01, *P < 0.05.
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serovars Ba, D and L2 24 hours p.i. were considered for
further analysis (Figure 7).
As depicted in Figure 7, Serovar Ba induced up regula-
tion of 11 genes, Serovar D of 11 genes and serovar L2 of
13 genes within infected monocytes. Of these up-regulated
genes 8 genes were common in all 3 serovars which in-
cluded receptor for bacterial components (PGLYRP3)
and genes responsible for antibacterial defense (DEF4BA,
CCL2). Cytokine genes inducing antiviral effect (IFNA1,
IFNB1) as well as immune-regulation (IL-10) were also el-
evated emphasizing the cytokine interplay in infected
monocyte. It is noteworthy that Toll-like receptor (TLR) 3
which recognizes dsRNA and is crucial for the TRIF medi-
ated immune response pathway (MyD88 independent)
was up-regulated. TREM1 gene, which is an important
sepsis marker, was elevated in serovar L2 infected
monocytes.
The down-regulated genes in the infected monocytes
numbered 19 for serovar Ba, 15 for serovar D and 14 forserovar L2 (Figure 7). Ten of those genes were common
for all the 3 serovars which included a member of
Myd88 dependent pathway (TLR8) and interacting pro-
tein (TOLLIP). Other genes involved were predomin-
antly involved in vascular mechanism (PTAFR, PPBP,
FN1 and COLEC12). Additionally, some genes involved
in apoptosis and oxidative process (CHUK, NCF4 and
NLRC4) were also down-regulated.
DCs response to the chlamydial serovars were also in-
triguing. There was up regulation of 4 genes by serovar
Ba, 7 genes by serovar D and 10 genes by serovar L2
(Figure 7). The remarkable observation was that serovars
Ba, D and L2 could all up regulate TLR8 as well other
TLRs individually (TLR, 2, 4 and 6), all belonging to the
Myd88 dependent signalling pathway [47].
The genes down regulated in DCs in response to chla-
mydial infection numbered 4 for serovar Ba, 5 for sero-
var D and 5 for serovar L2. Two genes were common
which included anti-inflammatory effector (IL-10) as
well as gene involved in vascular process (COLEC12).
Figure 5 Indolamine 2, 3- dioxygenase (IDO) gene regulation in chlamydiae-infected monocytes and DCs. Monocytes and monocyte-derived
DCs were infected with C. trachomatis serovars Ba, D and L2 (MOI-3) and mock control. IDO gene copy numbers was determined by isolating
RNA at the indicated time points followed by real-time PCR as described in materials and methods. IDO fold change was normalized to 18S
rRNA and determined by ddCt method with mock sample as reference gene. The mean of 3 independent experiments is shown and each
experiment is pool of 2 donors. ***P < 0.001, **P < 0.01, *P < 0.05.
Datta et al. BMC Microbiology 2014, 14:209 Page 9 of 14
http://www.biomedcentral.com/1471-2180/14/209Discussion
In our study we could demonstrate that the different
serovars of C. trachomatis experience altered fate in
monocytes and DCs by virtue of the variable host im-
mune response induced by infection. Monocytes and
DCs could be primarily infected by C. trachomatis sero-
vars Ba, D and L2 in comparable degree. This is in
agreement with previous study showing similar results
in terms of primary infection of DCs by C. trachomatis
[31]. To our knowledge, no such study has been re-
ported for monocytes, hence we report here for the first
time characteristics of C. trachomatis serovars Ba, D and
L2 infection in monocytes. The infection percentages
were comparable for serovar Ba and D while serovar L2experienced a slightly higher rate in both monocytes and
DCs infection. Incidentally the percentage declined in
infected DCs with longer culture period for all the three
serovars. The variable inclusion morphology and lower
infection rate within chlamydiae-infected monocytes and
DCs as opposed to in HeLa indicated that replication
cycle of C. trachomatis was somewhat restricted in these
two immune cell types.
Attempts to recover infectious particles from the
monocytes and DCs infected with the chlamydia sero-
vars led to an interesting observation. Monocytes in-
fected with serovars Ba and D when passaged to HeLa
cells could not produce any inclusions, which is in ac-
cordance with earlier studies demonstrating inability of
Figure 6 Cytokine concentration in chlamydiae-infected monocytes and monocyte-derived DCs. Monocytes and monocyte-derived DCs
were infected with C. trachomatis serovars Ba, D and L2 (MOI-3) and mock control. Supernatants were collected 1 day post infection and the
concentration of the different cytokines IL-1β, TNF, IL-6, IL-8 and IL-10 were determined by using the kit Cytometric Bead Array. The concentration
is reported as pg/ml. The cytokine secreted by heat-killed sample of each serovar were quantified and are indicated for each dataset. The mean
of 3 independent experiments is shown and each experiment is pool of 2 donors. ***P < 0.001, **P < 0.01, *P < 0.05.
Datta et al. BMC Microbiology 2014, 14:209 Page 10 of 14
http://www.biomedcentral.com/1471-2180/14/209serovar K to productively infect monocytes [23,24]. In
contrast to earlier observations [48] where mononuclear
cells were considered to be microbicidal for all C. tra-
chomatis serovars our results revealed that serovar L2
could productively infect monocytes.
A similar trend was observed in DCs, where serovar
Ba and serovar D showed abortive infection with no typ-
ical inclusions. Infectious particles could only be recov-
ered from serovar L2 infected DCs as has been reported
previously by Gervassi et al. [31]. However Gervassi
et al. showed that serovar E passaged in DCs could be
further propagated in HeLa cell whereas in our study
serovar D, member of the same biovariant could not be
propagated in HeLa cells. The differences between these
findings can be caused by effects of genetic human host
polymorphism (source of DCs are different), differences in
culture condition (10% FCS vs 10% autologous serum), or
use of different MOIs 10 vs 3).
In conjunction with the reinfection data, high expres-
sion levels of 16S rRNA within monocytes infected withserovars Ba, D and L2 indicated that C. trachomatis ser-
ovars were viable throughout the infection period, even
though infectious progeny could only be recovered from
L2 infected monocytes. This phenomenon of viability
without producing infectious bodies is known as chla-
mydial persistence [18,49]. Serovar K infection of mono-
cytes resulted in attenuation of new EB production
although genes involved in chlamydial DNA replication
were expressed during persistence [20]. Nevertheless our
study establishes that this is a general phenomenon oc-
curring in monocytes for several serovars of C. tracho-
matis biovariants. Contrasting observations are provided
by DCs infected with the chlamydial serovars. The ab-
sence of recovered infectious progeny along with the
negligible expression of 16S rRNA in serovars Ba and D
in infected DCs 2 days p.i. suggest the loss of metabolic
activity of C. trachomatis serovars within DCs. This loss
of metabolic activity of C. trachomatis serovars within
DCs indicated towards a probable degradation of chla-
mydiae. Serovar L2 could however, produce inclusions
Figure 7 Genes up-regulated or down-regulated in response to C. trachomatis infection in monocytes and DCs. Expression of Innate and
adaptive immune response genes were studied by PCR array in monocytes and DCs infected with Chlamydia trachomatis serovars Ba, D and L2.
RNA samples were transcribed into cDNA and expression studied by real-time PCR. The change in fold was studied by ddCt method and genes
regulated 1.5 fold up or below the mock control are only included. The mean of 3 independent experiments is shown and each experiment is
pool of 2 donors.
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p.i. in DCs but suffered rapid decline in viability 3 days
p.i.. DCs have shown the ability to degrade Chlamydia
psittaci and C. trachomatis MoPn [29] but other DC- C.
trachomatis studies have shown contrasting results, where
they showed that C. trachomatis serovars were confined
within specific vacuoles within DCs being able to replicate
[30,31]. Our results were in contrast to Chlamydiapneumoniae infected DCs showing an increase in 16S
rRNA expression when infected for 3 days [34]. The study
of the chlamydial developmental cycle within the mono-
cytes and DCs by expression of stage-specific genes
showed a clear prominence of serovar L2 compared to
serovars Ba and D. The observed gene expression for sero-
var L2 was in accordance with the expected early, mid and
late phase patterns and therefore indicative of presence of
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tween serovar L2 and the serovars Ba and D indicates the
infection severity. The expression of ompA and omcB
genes for serovars Ba and D, within monocytes and DCs,
at later time points indicate that some chlamydiae were
still viable. While in monocytes these chlamydia were in
persistent form, it is possible that in DCs transient level of
C. trachomatis development is allowed while predomin-
antly inhibiting or degrading the pathogen as it has been
reported previously for other monocytic cells [50].
The presence of a functional tryptophan synthase gene
in urogenital serovars and the absence of it in ocular ser-
ovars has been related with tissue tropism [35,37]. The
tryptophan synthase gene enables the bacteria to use in-
dole as a substrate for tryptophan synthesis when the
intracellular tryptophan is depleted by IDO induction
during chlamydial infection. In this study, we have
shown that IDO expression levels for ocular serovar Ba
and urogenital serovar D were similar while LGV serovar
L2 showed down-regulation in infected monocytes. In
infected DCs, IDO expression was significantly up-
regulated for serovar L2 but declined rapidly in the other
two serovars. The involvement of TNF secreted by DCs
(Figure 6) seemed to be crucial in the up-regulation of
IDO, as TNF has been earlier reported to activate IDO
expression in human DCs [51]. The heightened level of
IDO in serovar L2 could not restrict its active infection
probably due to the presence of functional tryptophan
synthase in genital serovars as discussed above. IDO ex-
pression revealed analogous pattern for serovars Ba and
D in both monocytes and DCs which poses a query
whether the organotropism is less pronounced within
the immune cells.
In infected monocytes the pro-inflammatory cytokines
TNF and IL-1β were secreted in higher levels than mock
which might be the reason for the restricted chlamydial
growth observed, higher secretion of these cytokines has
also been reported previously [45]. The significance of
TNF in serovar D and L2 infected DCs confirmed their
role in restricting chlamydial growth. The inflammatory
cytokines IL-8 and IL-6 although secreted in higher
levels by the infected monocytes were not significant.
One probable reason for such high volumes could be
due to the monocyte adherence for 2 hours prior infec-
tion which might have induced some activation. The fact
that IL-10 was highly induced by serovars Ba, D and L2
within monocytes demonstrates the critical role played
by the anti-inflammatory process to prevent degradation
of chlamydia and remain viable within the monocytes.
DC infection with serovars Ba, D and L2 could induce
significant levels of inflammatory cytokines IL-6 and IL-
8. The anti-inflammatory IL-10 was secreted in low
levels by the serovars, thus displaying dominance of the
inflammatory process in DC infection. The distinctinterplay of pro-inflammatory and anti-inflammatory cy-
tokines seemed to play role in infection outcome within
monocytes and DCs. The cytokine studies with heat-
killed EBs showed that TNF was induced by active infec-
tion of DCs by serovars D and L2. Infection by viable
chlamydia could only induce secretion of IL-10 in
monocytes, indicating that an active infection is essential
for inducing these particular cytokines in monocytes or
DCs. The data demonstrated that monocytes and DCs
induce altered levels of cytokines in response to chla-
mydial infection, and DCs demonstrate a stronger in-
flammatory role than the monocytes.
Our data manifested distinct activation profiles of im-
mune genes in monocytes and DCs during C. trachomatis
infection. Although, the fold-regulation was not signifi-
cant, the differential regulation of the different genes when
analysed through functional annotation tool, David for
Bioinformatics, could reveal an interesting pattern. The
hallmark of this response was the involvement of the Toll
like receptor (TLR) signalling pathway-critical mediators
of innate immune response recognizing different micro-
bial components [52-54]. On contact with their ligands,
TLRs engage different adapter molecules to propagate the
downstream signalling. The adapter molecule MyD88 is
used by all the TLRs (except TLR3) to activate the tran-
scriptional activator NF-κB and induce secretion of TNF,
IL-6 and other inflammatory cytokines thus forming the
MyD88 dependent pathway [47,55]. The other pathway
recruits TRIF adapter molecule to induce IFNβ and late
induction of NF-κB constituting the MyD88 independent
pathway [47,56]. TLR3 is able to signal exclusively through
MyD88-independent pathway [57]. The involvement of
TLR2 and TLR4 in C. trachomatis mediated infection re-
sponse has been reported by earlier studies [58,59]. In our
studies the up-regulation of TLR3, IFNA1, IFNB1 for ser-
ovars Ba, D and L2 in infected monocytes and the simul-
taneous down regulation of TLR1, TLR8 suggests the
dominance of the TRIF mediated signalling in C. tracho-
matis infected monocytes. The converse could be seen in
C. trachomatis infected DCs where TLR8 was up-
regulated for all the serovars and TLR/2/4/6 of MyD88
signalling pathway were differentially up-regulated for the
different serovars. With the array findings, one could
speculate that two distinct immune response pathways are
employed by monocytes and DCs when infected with spe-
cific chlamydial serovars. The results could be further
studied in detail to ascertain the role played by the differ-
ent adapter mediated signalling pathways in chlamydia
infection.
Conclusion
Our study demonstrated that C. trachomatis serovars Ba,
D and L2 infected monocytes and DCs in a comparable
manner; however, they underwent differential infection
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monocytes while they degraded within DCs. Serovar L2
could, however, maintain the development cycle in both
monocytes and DCs, although the process was severely
impaired. The heightened levels of inflammatory cytokines
secreted by the chlamydial infection in DCs compared to
monocytes could be instrumental to the differences ob-
served. The host immune genes response to infection dis-
played distinct activation profile within monocytes and
DCs. Collectively, we could establish that the host patho-
gen interaction in chlamydia infection is not only serovar
specific but also cell specific.
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